Bar-Sagi D, Feramisco J R
Cell. 1985 Oct;42(3):841-8. doi: 10.1016/0092-8674(85)90280-6.
To investigate the possible role of ras proteins in the differentiation process signaled by nerve growth factor, we have microinjected the proto-oncogenic and oncogenic (T24) forms of the human H-ras protein into living rat pheochromocytoma cells (PC12). PC12 cells, which have the phenotype of replicating chromaffin-like cells under normal growth conditions, respond to nerve growth factor by differentiating into nonreplicating sympathetic neuron-like cells. Microinjection of the ras oncogene protein promoted the morphological differentiation of PC12 cells into neuron-like cells. In contrast, microinjection of similar amounts of the proto-oncogene form of the ras protein had no apparent effect on PC12 cells. The induction of morphological differentiation by the ras oncogene protein occurred in the absence of nerve growth factor, was dependent on protein synthesis, and was accompanied by cessation of cell division. Treatment of PC12 cells with nerve growth factor or cAMP analogue prior to injection did not alter the phenotypic changes induced by the ras oncogene protein.
为了研究Ras蛋白在神经生长因子所介导的分化过程中可能发挥的作用,我们已将人H-Ras蛋白的原癌基因形式和致癌基因形式(T24)显微注射到活的大鼠嗜铬细胞瘤细胞(PC12)中。PC12细胞在正常生长条件下具有类嗜铬细胞的复制表型,对神经生长因子的反应是分化为不进行复制的类交感神经元细胞。显微注射Ras癌基因蛋白可促进PC12细胞向神经元样细胞的形态分化。相比之下,显微注射等量的Ras蛋白原癌基因形式对PC12细胞没有明显影响。Ras癌基因蛋白诱导的形态分化在没有神经生长因子的情况下发生,依赖于蛋白质合成,并伴随着细胞分裂的停止。在注射前用神经生长因子或cAMP类似物处理PC12细胞,不会改变Ras癌基因蛋白诱导的表型变化。